Shu Wang

6.0k total citations · 2 hit papers
144 papers, 3.3k citations indexed

About

Shu Wang is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Shu Wang has authored 144 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Molecular Biology, 20 papers in Oncology and 18 papers in Genetics. Recurrent topics in Shu Wang's work include Phytochemical Studies and Bioactivities (11 papers), Viral Infectious Diseases and Gene Expression in Insects (8 papers) and Virus-based gene therapy research (8 papers). Shu Wang is often cited by papers focused on Phytochemical Studies and Bioactivities (11 papers), Viral Infectious Diseases and Gene Expression in Insects (8 papers) and Virus-based gene therapy research (8 papers). Shu Wang collaborates with scholars based in China, United States and Singapore. Shu Wang's co-authors include Jiannan Li, Dongdong Wang, Qian Yong, Jin‐Song Bian, Dejian Huang, Ling Hu, Chaoyang Wang, Xiong Chen, Jingyi Zhu and Jinhuan Chen and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Blood.

In The Last Decade

Shu Wang

134 papers receiving 3.2k citations

Hit Papers

Treatment of Inflammatory Bowel Disease: A Comprehensive ... 2021 2026 2022 2024 2021 2022 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shu Wang China 30 1.4k 450 345 329 294 144 3.3k
Wei Qin China 30 1.3k 0.9× 233 0.5× 427 1.2× 192 0.6× 323 1.1× 131 3.2k
Chen Ma China 30 1.0k 0.7× 435 1.0× 179 0.5× 212 0.6× 482 1.6× 191 3.3k
Eliezer A. Rachmilewitz Israel 44 1.4k 1.0× 330 0.7× 464 1.3× 319 1.0× 301 1.0× 169 7.7k
Mohammed Al‐Qahtani Saudi Arabia 31 1.3k 0.9× 219 0.5× 248 0.7× 213 0.6× 238 0.8× 150 3.2k
Yue Dai China 43 2.3k 1.7× 696 1.5× 289 0.8× 319 1.0× 301 1.0× 185 5.2k
Kieran F. Scott Australia 31 1.1k 0.8× 294 0.7× 231 0.7× 119 0.4× 343 1.2× 88 3.5k
Mitchell D. Knutson United States 44 1.7k 1.2× 163 0.4× 537 1.6× 330 1.0× 156 0.5× 77 7.4k
Qing Jiang United States 35 1.8k 1.3× 311 0.7× 198 0.6× 101 0.3× 290 1.0× 81 5.3k
Nathalie Séta France 37 2.0k 1.4× 376 0.8× 581 1.7× 224 0.7× 263 0.9× 148 4.3k
C. Kennedy Canada 41 1.7k 1.2× 528 1.2× 239 0.7× 81 0.2× 293 1.0× 118 4.7k

Countries citing papers authored by Shu Wang

Since Specialization
Citations

This map shows the geographic impact of Shu Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu Wang more than expected).

Fields of papers citing papers by Shu Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shu Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu Wang. The network helps show where Shu Wang may publish in the future.

Co-authorship network of co-authors of Shu Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Shu Wang. A scholar is included among the top collaborators of Shu Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shu Wang. Shu Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rabik, Cara A., Shu Wang, Donna Przepiorka, et al.. (2025). FDA Approval Summary: Blinatumomab for the Treatment of B-Cell Precursor Acute Lymphoblastic Leukemia in the Consolidation Phase of Multiphase Chemotherapy. Clinical Cancer Research. 31(20). 4230–4238.
4.
Liu, Yaosheng, Wenliang Chen, Zhihong Li, et al.. (2024). Isaridin E Protects against Sepsis by Inhibiting Von Willebrand Factor-Induced Endothelial Hyperpermeability and Platelet–Endothelium Interaction. Marine Drugs. 22(6). 283–283. 3 indexed citations
5.
Bansal, Shivani, Shu Wang, Yaoxiang Li, et al.. (2024). Abstract 1074: Plasma EV profiling facilitates low abundance biomarker discovery in pancreatic cancer. Cancer Research. 84(6_Supplement). 1074–1074.
7.
Yang, Changlin, Andria Doty, Shu Wang, et al.. (2022). Slow-Cycling Cells in Glioblastoma: A Specific Population in the Cellular Mosaic of Cancer Stem Cells. Cancers. 14(5). 1126–1126. 7 indexed citations
8.
Yang, Ruiyue, Jun Dong, Haijian Zhao, et al.. (2014). Association of Branched-Chain Amino Acids with Carotid Intima-Media Thickness and Coronary Artery Disease Risk Factors. PLoS ONE. 9(6). e99598–e99598. 80 indexed citations
9.
Yang, Ruiyue, et al.. (2012). Determination of serum cotinine by isotope dilution liquid chromatography tandem mass spectrometry. Zhonghua jianyan yixue zazhi. 35(4). 333–338.
10.
Wang, Shu. (2012). Effect of Polysaccharides from Astragalus on Blood Lipid, Immune Function and Oxidative Stress in Hyperlipidemic Rats. 1 indexed citations
11.
Li, Hui‐Jun, et al.. (2010). Molecular method for the identification of Buibus Fritillariae Cirrhosae.. Zhongguo yaoke daxue xuebao. 41(3). 226–230. 4 indexed citations
12.
Wang, Shu. (2010). Study on the relative in molecular biology among Fritillariae of Sichuan species. Huaxi yaoxue zazhi. 3 indexed citations
13.
Yang, Jingyu, Guoliang Chen, Lihui Wang, et al.. (2008). Effects of resveratrol and its derivatives on lipopolysaccharide-induced microglial activation and their structure–activity relationships. Chemico-Biological Interactions. 174(1). 51–59. 73 indexed citations
14.
Wang, Shu. (2007). Study on Biological Activity of Two Modified Anti-tumor Peptide of Tumstatin. PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS. 2 indexed citations
15.
Wang, Shu, Xiaofeng Tian, & Liming Wang. (2007). Growth inhibition effect of DL-lysine acetylalicylate on sw480 colon carcinoma cells. Chinese Journal of Cancer Research. 19(1). 18–21. 1 indexed citations
16.
Wang, Shu. (2006). The phytochemical research of Swertia chirayita. Huaxi yaoxue zazhi. 4 indexed citations
17.
Wang, Shu. (2005). Expression and correlation of nuclear factor-kappa B and survivin in epithelial ovarian tumor. Di-Si Junyi Daxue xuebao. 1 indexed citations
18.
Wang, Shu. (2004). Studies on Molecular Recognition of Imidazole Derivatives by Novel Chiral Tyrosine Tetraphenylporphinatozinc Complex. Chemical Research in Chinese Universities. 1 indexed citations
19.
Wang, Shu. (2001). Clonality of uterine leiomyomas, an assay using X chromosome polymorphism at the phosphoglycerate kinase locus. Di-Si Junyi Daxue xuebao. 2 indexed citations
20.
Wang, Shu. (2000). Preliminary Studies on the Culture of Transgenic Synechocystis sp. PCC6803 with Mouse Metallothionein Gene and Synechocystis sp. PCC6803. Huadong Li-Gong Daxue xuebao. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026